Biosyntia lands €11.5M funding, eyes vitamin B7 commercialization

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

This week in industry news, US-based Perfect Day allies with Onego Bio to accelerate the time needed to create animal-free eggs. Marinova announces expansion of its... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

US-based Layn Natural Ingredients is launching a natural antioxidant flavonoid called bio+Quercetin, which it touts as a “highly bioavailable form of quercetin for... Read More

FormattedPicture

FOOD RESEARCH

Six months of wild blueberry consumption helps improve the elderly population’s information processing speed, reducing cognitive aging effects. Throughout the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Ingredients by Nature (IBN) has received self-affirmed Generally Recognized as Safe (GRAS) status for Eriomin, its lemon flavonoid. The ingredient – which delivers... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, DSM created a new integrated Food & Beverage group to align more closely with emerging customer and market needs. The F&B platform... Read More

trans